Major depressive disorder has become one of the most serious neuropsychiatric disorders worldwide. However, currently available antidepressants used in clinical practice are ineffective for a substantial proportion of patients and always have side effects. Besides being a lipid-regulating agent, gemfibrozil is an agonist of peroxisome proliferator-activated receptor-α (PPAR-α). We investigated the antidepressant effects of gemfibrozil on C57BL/6J mice using the forced swim test (FST) and tail suspension test (TST), as well as the chronic unpredictable mild stress (CUMS) model of depression. The changes in brain-derived neurotrophic factor (BDNF) signaling cascade in the brain after CUMS and gemfibrozil treatment were further assessed. Pharmacological inhibitors and lentivirus-expressed short hairpin RNA (shRNA) were also used to clarify the antidepressant mechanisms of gemfibrozil. Gemfibrozil exhibited significant antidepressant actions in the FST and TST without affecting the locomotor activity of mice. Chronic gemfibrozil administration fully reversed CUMS-induced depressive-like behaviors in the FST, TST and sucrose preference test. Gemfibrozil treatment also restored CUMS-induced inhibition of the hippocampal BDNF signaling pathway. Blocking PPAR-α and BDNF but not the serotonergic system abolished the antidepressant effects of gemfibrozil on mice. Gemfibrozil produced antidepressant effects in mice by promoting the hippocampal BDNF system.
AlbertPRBenkelfatCDescarriesL (2012) The neurobiology of depression – revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philos Trans R Soc Lond B Biol Sci367: 2378–2381.
2.
BadescuSVTataruCPKobylinskaLet al. (2016) Effects of caffeine on locomotor activity in streptozotocin-induced diabetic rats. J Med Life9: 275–279.
3.
Berghauzen-MaciejewskaKWardasJKosmowskaBet al. (2015) Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson’s disease: An influence of chronic pramipexole in rats. PLoS One10: e0117698.
4.
BlazerDGKesslerRCMcGonagleKAet al. (1994) The prevalence and distribution of major depression in a national community sample: The national comorbidity survey. Am J Psychiatry151: 979–986.
5.
BorbaEMDuarteJABristotGet al. (2016) Brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to Alzheimer disease. Dement Geriatr Cogn Dis Extra6: 559–567.
6.
BourinMFioccoAJClenetF (2001) How valuable are animal models in defining antidepressant activity?Hum Psychopharmacol16: 9–21.
7.
BuddAAllevaLAlsharifiMet al. (2007) Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother51: 2965–2968.
8.
CastrenERantamakiT (2010) The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol70: 289–297.
9.
CorbettGTGonzalezFJPahanK (2015) Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci USA112: 8445–8450.
10.
CorbettGTRoyAPahanK (2012) Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: Implications for neuronal self-defense. J Immunol189: 1002–1013.
11.
CryanJFHolmesA (2005) The ascent of mouse: Advances in modelling human depression and anxiety. Nat Rev Drug Discov4: 775–790.
de KloetERMolendijkML (2016) Coping with the forced swim stressor: Towards understanding an adaptive mechanism. Neural Plast. Article ID: 6503162.
14.
EischAJBolanosCAde WitJet al. (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biol Psychiatry54: 994–1005.
15.
GatchMBDolanSBForsterMJ (2017) Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats. Psychopharmacology234: 1237–1245.
16.
GourleySLWuFJKiralyDDet al. (2008) Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry63: 353–359.
17.
GuoQWangGLiuXet al. (2009) Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res1279: 121–130.
18.
HirschfeldRM (2012) Depression epidemiology and its treatment evolution. J Clin Psychiatry73: e29.
19.
JeonSWKimYK (2016) Molecular neurobiology and promising new treatment in depression. Int J Mol Sci17: 381.
20.
JiangBHuangCZhuQet al. (2015) WY14643 produces anti-depressant-like effects in mice via the BDNF signaling pathway. Psychopharmacology232: 1629–1642.
21.
JiangBWangFYangSet al. (2014) SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway. Int J Neuropsychopharmacol18: pii: pyu096. doi: 10.1093/ijnp/pyu096
22.
JiangBWangYJWangHet al. (2017) Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway. Br J Pharmacol174: 177–194.
23.
JiangBXiongZYangJet al. (2012) Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol166: 1872–1887.
24.
KhalajLNejadSCMohammadiMet al. (2013) Gemfibrozil pretreatment proved protection against acute restraint stress-induced changes in the male rats’ hippocampus. Brain Res1527: 117–130.
25.
KimYRKimHNHongKWet al. (2017) Antidepressant effects of aripiprazole augmentation for cilostazol-treated mice exposed to chronic mild stress after ischemic stroke. Int J Mol Sci18: pii: e355.
26.
KrishnanVHanMHGrahamDLet al. (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell131: 391–404.
27.
KrishnanVNestlerEJ (2008) The molecular neurobiology of depression. Nature455: 894–902.
28.
LiNLeeBLiuRJet al. (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science329: 959–964.
29.
LimJYParkSIOhJHet al. (2008) Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways. J Neurosci Res86: 2168–2178.
30.
MacQueenGMMemedovichKA (2017) Cognitive dysfunction in major depression and bipolar disorder: Assessment and treatment options. Psychiatry Clin Neurosci71: 18–27.
31.
MohagheghiFAhmadianiARahmaniBet al. (2013a) Gemfibrozil pretreatment resulted in a sexually dimorphic outcome in the rat models of global cerebral ischemia-reperfusion via modulation of mitochondrial pro-survival and apoptotic cell death factors as well as MAPKs. J Mol Neurosci50: 379–393.
32.
MohagheghiFKhalajLAhmadianiAet al. (2013b) Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion. Neurotox Res23: 225–237.
33.
NagaoKSakonoMNakayamaMet al. (1999) Effect of gemfibrozil on triacylglycerol synthesis and secretion by liver and lipoprotein lipase activity in adipose tissue of rats. Comp Biochem Physiol B Biochem Mol Biol124: 289–294.
34.
PappMMorylEWillnerP (1996) Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol296: 129–136.
35.
PetterssonRHagsaterSMErikssonE (2016) Serotonin depletion eliminates sex differences with respect to context-conditioned immobility in rat. Psychopharmacology233: 1513–1521.
36.
PolettiSAggioVHoogenboezemTAet al. (2017) Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder. Eur Psychiatry40: 33–37.
37.
PorsoltRDBertinAJalfreM (1977) Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther229: 327–336.
38.
ReidIForbesNStewartCet al. (1997) Chronic mild stress and depressive disorder: A useful new model?Psychopharmacology134: 365–367; discussion 371–377.
39.
RoyAJanaMCorbettGTet al. (2013) Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor alpha. Cell Rep4: 724–737.
40.
RoyAJanaMKunduMet al. (2015) HMG-CoA reductase inhibitors bind to PPARalpha to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab22: 253–265.
41.
SharinaIGSobolevskyMPapakyriakouAet al. (2015) The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: In vitro studies. Br J Pharmacol172: 2316–2329.
42.
ShaywitzAJGreenbergME (1999) CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem68: 821–861.
43.
SheltonRC (2007) The molecular neurobiology of depression. Psychiatr Clin North Am30: 1–11.
44.
ShirayamaYChakiS (2006) Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr Neuropharmacol4: 277–291.
45.
SinghAPSinghRKrishanP (2015) Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats. Cardiol Young25: 725–730.
46.
SongQLiuLYuJet al. (2017) Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress. Eur J Pharmacol807: 159–167.
47.
SteruLChermatRThierryBet al. (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology85: 367–370.
48.
StrackeJOttenWTuchschererAet al. (2017) Serotonin depletion induces pessimistic-like behavior in a cognitive bias paradigm in pigs. Physiol Behav174: 18–26.
49.
StrekalovaTGorenkovaNSchunkEet al. (2006) Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol17: 271–287.
50.
TornioANeuvonenPJNiemiMet al. (2017) Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters. Expert Opin Drug Metab Toxicol13: 83–95.
51.
YanHCQuHDSunLRet al. (2010) Fuzi polysaccharide-1 produces antidepressant-like effects in mice. Int J Neuropsychopharmacol13: 623–633.
52.
YaoWHuangLSunQet al. (2016) The inhibition of macrophage foam cell formation by tetrahydroxystilbene glucoside is driven by suppressing vimentin cytoskeleton. Biomed Pharmacother83: 1132–1140.
53.
ZhouSMGuanSYYangLet al. (2017) Cucurbitacin IIa exerts antidepressant-like effects on mice exposed to chronic unpredictable mild stress. Neuroreport28: 259–267.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
